Eléments de l'association
|
List of bibliographic references
Number of relevant bibliographic references: 19.Ident. | Authors (with country if any) | Title |
---|---|---|
002594 | Lanying Du [États-Unis] ; Guangyu Zhao ; Chris C S. Chan ; Lin Li ; Yuxian He ; Yusen Zhou ; Bo-Jian Zheng ; Shibo Jiang | A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity. |
002993 | Lanying Du [États-Unis] ; Yuxian He [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] ; Bo-Jian Zheng [République populaire de Chine] ; Shibo Jiang [États-Unis] | The spike protein of SARS-CoV — a target for vaccine and therapeutic development |
002A40 | Lanying Du [États-Unis] ; Guangyu Zhao [République populaire de Chine] ; Chris C. S. Chan [République populaire de Chine] ; Shihui Sun [République populaire de Chine] ; Min Chen [République populaire de Chine] ; Zhonghua Liu [États-Unis] ; Hongxiang Guo [États-Unis] ; Yuxian He [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Bo-Jian Zheng [République populaire de Chine] ; Shibo Jiang [États-Unis] | Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity |
002B80 | Lanying Du [États-Unis] ; Guangyu Zhao ; Lin Li ; Yuxian He ; Yusen Zhou ; Bo-Jian Zheng ; Shibo Jiang | Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. |
003634 | Zhongyu Zhu [États-Unis] ; Samitabh Chakraborti [États-Unis] ; Yuxian He [États-Unis] ; Anjeanette Roberts ; Tim Sheahan [États-Unis] ; Xiaodong Xiao ; Lisa E. Hensley [États-Unis] ; Ponraj Prabakaran ; Barry Rockx [États-Unis] ; Igor A. Sidorov ; Davide Corti ; Leatrice Vogel ; Yang Feng ; Jae-Ouk Kim [États-Unis] ; Lin-Fa Wang [Australie] ; Ralph Baric [États-Unis] ; Antonio Lanzavecchia ; Kristopher M. Curtis [États-Unis] ; Gary J. Nabel [États-Unis] ; Kanta Subbarao ; Shibo Jiang [États-Unis] ; Dimiter S. Dimitrov | Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies |
003D52 | Lanying Du [République populaire de Chine] ; Guangyu Zhao [République populaire de Chine] ; Yuxian He [République populaire de Chine, États-Unis] ; Yan Guo [République populaire de Chine] ; Bo-Jian Zheng [République populaire de Chine] ; Shibo Jiang [États-Unis] ; Yusen Zhou [République populaire de Chine] | Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model |
003E57 | Yuxian He [États-Unis] | Immunogenicity of SARS-CoV: the receptor-binding domain of S protein is a major target of neutralizing antibodies. |
003E69 | Yuxian He [États-Unis] ; Jingjing Li ; Lanying Du ; Xuxia Yan ; Guangan Hu ; Yusen Zhou ; Shibo Jiang | Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine. |
003F36 | Yuxian He [États-Unis] ; Jingjing Li ; Wenhui Li ; Sara Lustigman ; Michael Farzan ; Shibo Jiang | Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. |
003F79 | Yuxian He [États-Unis] ; Jingjing Li [États-Unis] ; Susanne Heck [États-Unis] ; Sara Lustigman [États-Unis] ; Shibo Jiang [États-Unis] | Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design |
004565 | Yuxian He [États-Unis] ; Shibo Jiang | Vaccine design for severe acute respiratory syndrome coronavirus. |
004665 | Shibo Jiang [États-Unis] ; Yuxian He [États-Unis] ; Shuwen Liu [États-Unis] | SARS Vaccine Development |
004684 | Yuxian He [États-Unis] ; Hong Lu ; Pamela Siddiqui ; Yusen Zhou ; Shibo Jiang | Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. |
004807 | Yuxian He [États-Unis] ; Qingyu Zhu [République populaire de Chine] ; Shuwen Liu [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Baoan Yang [République populaire de Chine] ; Jiaming Li [République populaire de Chine] ; Shibo Jiang [États-Unis] | Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines |
005170 | Yuxian He [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Shuwen Liu [États-Unis] ; Zhihua Kou [République populaire de Chine] ; Wenhui Li [États-Unis] ; Michael Farzan [États-Unis] ; Shibo Jiang [États-Unis] | Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine |
005251 | Yuxian He [États-Unis] ; Yusen Zhou ; Hao Wu ; Zhihua Kou ; Shuwen Liu ; Shibo Jiang | Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus. |
005279 | Shuwen Liu [États-Unis] ; Gengfu Xiao [République populaire de Chine] ; Yibang Chen [États-Unis] ; Yuxian He [États-Unis] ; Jinkui Niu [États-Unis] ; Carlos R. Escalante [États-Unis] ; Huabao Xiong [États-Unis] ; James Farmar [États-Unis] ; Asim K. Debnath [États-Unis] ; Po Tien [République populaire de Chine] ; Shibo Jiang [États-Unis] | Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors |
005293 | Yuxian He [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Pamela Siddiqui [États-Unis] ; Shibo Jiang [États-Unis] | Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry |
005307 | Yuxian He [États-Unis] ; Yusen Zhou ; Hao Wu ; Baojun Luo ; Jingming Chen ; Wanbo Li ; Shibo Jiang | Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. |
This area was generated with Dilib version V0.6.33. |